Ts. Russell et al., ERADICATION OF CRYPTOSPORIDIUM IN A CHILD UNDERGOING MAINTENANCE CHEMOTHERAPY FOR LEUKEMIA USING HIGH-DOSE AZITHROMYCIN THERAPY, Journal of pediatric hematology/oncology, 20(1), 1998, pp. 83-85
Purpose: To describe a case of severe diarrhea caused by Cryptosporidi
um in a patient undergoing maintenance chemotherapy. Important aspects
of disease caused by Cryptosporidium, including diagnosis and treatme
nt, are also reviewed. Methods and Results: A 4-year-old boy with acut
e lymphoblastic anemia in remission had a prolonged course of diarrhea
and wasting. C parvum was identified in the gastrointestinal tract by
biopsy and in the stool using modified acid fast staining. Improvemen
t in the stool consistency was noted after 3 days of therapy with azit
hromycin, and, after 14 days of therapy, Cryptosporidium oocysts could
no longer be identified in the stool. Conclusions: C parvum should be
considered in all immunocompromised patients with severe or prolonged
diarrhea, especially if there is no blood or leukocytes in the stool.
Because Cryptosporidium is not always tested for in a routine ova and
parasite examination, the lab should be notified if it is in the diff
erential diagnosis. Azithromycin therapy may prove beneficial in the t
reatment of intestinal Cryptosporidium in immunocompromised individual
s.